Imaging method, imaging apparatus, imaging system, surgery support system, and a storage medium

US10408749B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10408749-B2
Application numberUS-201815922999-A
CountryUS
Kind codeB2
Filing dateMar 16, 2018
Priority dateSep 18, 2015
Publication dateSep 10, 2019
Grant dateSep 10, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An imaging method includes: irradiating breast tissue with infrared light, detecting light in a narrow wavelength band selected from wavelength bands from 1400 nm or more to 1600 nm or less, among light radiated from the tissue irradiated with the infrared light, and generating, based on the detected light in the narrow wavelength band, an image to specify an area in the tissue containing breast cancer cell aggregation or breast cancer tissue.

First claim

Opening claim text (preview).

What is claimed is: 1. An imaging method comprising: irradiating breast tissue with infrared light; detecting light in a narrow wavelength band selected from wavelength bands from 1400 nm or more to 1650 nm or less, among light radiated from the tissue irradiated with the infrared light; and generating, based on the detected light in the narrow wavelength band, an image to specify an area in the tissue containing breast cancer cell aggregation or breast cancer tissue, wherein a peak wavelength of the infrared light is set to 1400 nm or more to 1650 nm or less, wherein the infrared light has a spectral half width of 100 nm or less. 2. The imaging method of claim 1 , wherein the narrow wavelength band is selected based on optical properties of water and optical properties of fat. 3. The imaging method of claim 1 , wherein the light in the narrow wavelength band is light having a wavelength of 1400 nm, 1500 nm, or 1600 nm. 4. The imaging method of claim 1 , wherein the breast cancer cell aggregation or the breast cancer tissue includes an invasive ductal carcinoma. 5. The imaging method of claim 1 , wherein the breast cancer cell aggregation or the breast cancer tissue includes a ductal carcinoma in situ. 6. The imaging method of claim 1 , wherein the tissue includes a non-nodular lesion. 7. The imaging method of claim 1 , wherein the tissue includes a nodular lesion with adipose tissue as a background. 8. An imaging apparatus comprising: an irradiator that irradiates breast tissue with infrared light; a detector that detects light in a narrow wavelength band selected from wavelength bands from 1400 nm or more to 1650 nm or less, among light radiated from the tissue irradiated with the infrared light; and an image generator that generates, based on detection results from the detector, an image to specify an area in the tissue containing breast cancer cell aggregation or breast cancer tissue, wherein a peak wavelength of the infrared light is set to 1400 nm or more to 1650 nm or less, wherein the infrared light has a spectral half width of 100 nm or less. 9. The imaging apparatus of claim 8 , wherein the narrow wavelength band is selected based on optical properties of water and optical properties of fat. 10. The imaging apparatus of claim 8 , wherein the light in the narrow wavelength band is light having a wavelength of 1400 nm, 1500 nm, or 1600 nm. 11. The imaging apparatus of claim 8 , wherein the irradiator includes a light emitting diode or a laser diode. 12. The imaging apparatus of claim 8 , wherein the breast cancer cell aggregation or the breast cancer tissue includes an invasive ductal carcinoma. 13. The imaging apparatus of claim 8 , wherein the breast cancer cell aggregation or the breast cancer tissue includes a ductal carcinoma in situ. 14. The imaging apparatus of claim 8 , wherein the tissue includes a non-nodular lesion. 15. The imaging apparatus of claim 8 , wherein the tissue includes a nodular lesion with adipose tissue as a background. 16. An imaging system comprising: the imaging apparatus of claim 8 ; and a display device that displays images of the tissue captured by the imaging apparatus. 17. The imaging system of claim 16 comprising: a second imaging apparatus that detects a visible light image of the tissue. 18. A surgery support system comprising: the imaging apparatus of claim 8 ; and an operation device that is capable of processing the tissue. 19. An imaging apparatus comprising: an irradiator that irradiates tissue with infrared light; a detector that detects first light in a wavelength band selected from predetermined wavelength bands from 1050 nm or more to 1650 nm or less, among light radiated from the tissue irradiated with the light; and an image generator that generates, based on detection results from the detector, an image to specify a breast cancer area in the tissue, wherein the infrared light has a spectral half width of 100 nm or less. 20. The imaging apparatus of claim 19 , wherein the selected wavelength band is selected based on optical properties of water or optical properties of fat. 21. The imaging apparatus of claim 6 , wherein the detector detects second light in a wavelength band, the wavelength band being selected from the predetermined wavelength bands from 1050 nm or more to 1650 nm or less and being different from the wavelength band of the first light, and the image generator generates, based on detection results from the detector after detecting the second light, an image to specify a breast cancer area in the tissue. 22. The imaging apparatus of claim 19 , wherein the first light has a wavelength selected from 1350 nm or more to 1650 nm or less. 23. The imaging apparatus of claim 19 , wherein the first light is light having a wavelength of 1400 nm, 1500 nm, or 1600 nm. 24. The imaging apparatus of claim 19 , wherein the first light is light having a wavelength of 1070 nm or 1300 nm. 25. The imaging apparatus of claim 19 , wherein the image generator generates the image in which the breast cancer area is enhanced. 26. The imaging apparatus of claim 19 , wherein the image generator generates the image in which contract is adjusted. 27. The imaging apparatus of claim 19 , wherein the detector includes a filter that interrupts light other than light in a wavelength band selected from the predetermined wavelength bands. 28. The imaging apparatus of claim 19 , wherein the breast cancer area includes an invasive ductal carcinoma. 29. The imaging apparatus of claim 19 , wherein the breast cancer area includes a ductal carcinoma in situ. 30. The imaging apparatus of claim 19 , wherein the tissue includes a non-nodular lesion. 31. The imaging apparatus of claim 19 , wherein the tissue includes a nodular lesion with adipose tissue as a background. 32. An imaging system comprising: the imaging apparatus of claim 19 ; and a display device that displays images of the tissue captured by the imaging apparatus. 33. A storage medium storing therein a control program that causes a computer to control processing comprising: irradiating breast tissue with infrared light; detecting light in a narrow wavelength band selected from wavelength bands from 1400 nm or more to 1650 nm or less, among light radiated from the tissue irradiated with the infrared light; and generating, based on the detected light in the narrow wavelength band, an image to specify an area in the tissue containing breast cancer cell aggregation or breast cancer tissue, wherein a peak wavelength of the infrared light is set to 1400 nm or more to 1650 nm or less, wherein the infrared light has a spectral half width of 100 nm or less. 34. A storage medium storing therein a control program that causes a computer to control processing comprising: irradiating tissue with infrared light; detecting first light in a narrow wavelength band selected from wavelength bands from 1050 nm or more to 1650 nm or less, among light radiated from the tissue irradiated with the infrared light; and generating, based on the detected first light, an image to specify a breast cancer area in the tissue, wherein the infrared light has a spectral half width of 100 nm or less.

Assignees

Inventors

Classifications

  • Pointed or sharp biopsy instruments · CPC title

  • for mammography · CPC title

  • Devices for viewing the surface of the body, e.g. camera, magnifying lens · CPC title

  • Identification of persons (methods or arrangements for recognising patterns, e.g. fingerprints, G06F18/00, G06V40/00; identification of persons by analysing their voice or speech G10L17/00) · CPC title

  • Monitoring progression or stage of a disease · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10408749B2 cover?
An imaging method includes: irradiating breast tissue with infrared light, detecting light in a narrow wavelength band selected from wavelength bands from 1400 nm or more to 1600 nm or less, among light radiated from the tissue irradiated with the infrared light, and generating, based on the detected light in the narrow wavelength band, an image to specify an area in the tissue containing breas…
Who is the assignee on this patent?
Japan Organization Of Occupational Health And Safety, Aist, Nikon Corp
What technology area does this patent fall under?
Primary CPC classification G01N33/4833. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).